A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
書誌事項
- 公開日
- 2012-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- DOI
-
- 10.1016/j.ijrobp.2012.02.051
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- International Journal of Radiation Oncology*Biology*Physics
-
International Journal of Radiation Oncology*Biology*Physics 84 (5), 1166-1171, 2012-12
Elsevier BV